Eisai Co., Ltd. (ESALF)
OTCMKTS
· Delayed Price · Currency is USD
28.76
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Eisai Employees
Eisai had 11,067 employees as of March 31, 2024. The number of employees decreased by 9 or -0.08% compared to the previous year.
Employees
11,067
Change (1Y)
-9
Growth (1Y)
-0.08%
Revenue / Employee
$454,989
Profits / Employee
$33,789
Market Cap
8.01B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| SS Innovations International | 378 |
| Endo Inc. | 3,116 |
| Elite Pharmaceuticals | 64 |
| Northwest Biotherapeutics | 25 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Longduoduo Company | 49 |
Eisai News
- 8 days ago - Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion - Benzinga
- 9 days ago - Biogen/ Eisai win EU approval for Alzheimer’s therapy - Seeking Alpha
- 9 days ago - EU authorizes Eisai-Biogen's drug for treatment of early Alzheimer's disease - Reuters
- 22 days ago - Japanese Stocks Rise With Market Focused on U.S. Trade News - Barron's
- 7 weeks ago - LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer's Treatments| DelveInsight - Benzinga
- 7 weeks ago - EU regulator not updating opinion on Eisai-Biogen's Alzheimer's drug - Reuters
- 2 months ago - Eisai: Will Have No Problem Hitting Leqembi Forecasts - Seeking Alpha
- 2 months ago - Q3 2025 Eisai Co Ltd Earnings Presentation Transcript - GuruFocus